PDCD1 and ovarian cancer: Interestingly, recent studies in breast and ovarian cancer have highlighted the role of several subsets of cancer-associated fibroblasts in promoting an immunosuppressive environment resistant to anti-programmed cell death protein 1 (anti-PD-1) therapy, including one subset associated with the TGF-β signaling pathway49.